Tesidolumab (LFG316, 1531594-08-7): A Research Tool for Immunological Studies
Tesidolumab, identified as LFG316, bearing the CAS number 1531594-08-7, represents a valuable investigational instrument for advancing host defense research. The protein largely interacts with a defined receptor linked to autoimmune responses, making it to be used utilized to examine the basis of immune response. Investigators utilize Tesidolumab to gain insights into pathology occurrence and to discover novel treatment targets. Its availability as a compound allows thorough analysis within laboratory and in vivo systems.
```
```text
Investigating Tesidolumab (LFG316) in Research Applications
Investigators are actively examining the research utility of tesidolumab (LFG316) in several scientific settings . Early results suggest this compound could provide crucial perspectives into the mechanisms related to immune-mediated conditions . Specifically, ongoing investigations focus on assessing its effect on leukocyte function and protein production , with the goal of elucidating innovative biological markers and possibly facilitating next-generation treatment methodologies .
```
Tesidolumab LFG316: Investigating Potential Research Routes
Additional study into LFG316 LFG316 offers promising avenues for future analysis. Key areas of exploration could cover:
- Evaluating its efficacy in different individual groups, particularly those affected by severe autoimmune ailments.
- Defining the specific mode of effect and its impact on immune functions.
- Determining potential indicators that predict therapeutic result and permit for customized medicine.
- Assessing the long-term security history and identifying any potential adverse effects.
Research Grade Tesidolumab (1531594-08-7) – Characteristics and Applications
Tesidolumab, identified by the identifier 1531594-08-7, is a research grade protein currently explored for its therapeutic potential in autoimmune conditions . Stringent quality control is maintained through rigorous analytical testing processes, resulting in a product typically presenting a purity of ≥95% as assessed by HPLC . Usual preparations are available as a sterile, lyophilized powder, requiring reconstitution with a appropriate buffer. Potential applications for this therapeutic include, but are not limited to, preclinical studies focused on immune modulation . Further information regarding technical specifications can be accessed through the product datasheet .
- Molecular Weight : Approximately 155 kDa
- Recommended Storage: -20°C or colder
- Suggested Buffer: PBS
LFG316 for Research : Access and Administration
Accessing this therapeutic for experimental purposes requires careful consideration and adherence to strict guidelines . Currently, Tesidolumab is generally obtainable through specialized research reagent suppliers , often through a limited release program. Procurement typically involves a detailed application process specifying the intended research use . Managing this molecule demands expertise; it's usually Tesidolumab delivered in a frozen form requiring specific instruments for thawing and maintenance.
- Strict temperature regulation is imperative.
- Appropriate personal protective equipment must be employed .
- Debris elimination should follow designated institutional policies .
```text
Revealing Knowledge with the Compound: A Scientific Reagent (1531594-08-7)
Analysts working with Tesidolumab (1531594-08-7), a essential lab reagent, are beginning to reveal significant insights into challenging biological functions. This compound provides a distinct opportunity for studying disorder courses and possible medical targets. More experiments involving Tesidolumab indicate to yield important improvements in the area of biological science.
```